Profile of Kawasaki disease in children referred to two pediatric rheumatology services in Rio de Janeiro, Brazil

Revista Brasileira de Reumatologia

Volumn 50, Issue 5, 2010, Pages 534-538

  de Almeida, Rozana Gasparello ^a   Goldenzon, Andréa Valentim ^a   Rodrigues, Marta Cristine Félix ^b   Sztajnbok, Flávio Roberto ^b   Elsas, Maria Ignez Capella Gaspar ^c   de Oliveira, Sheila Knupp Feitosa ^b  

^a SMS/RJ ^*

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Antibiotic prophylaxis; Coronary artery disease; Mucocutaneous lymph node syndrome; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ANEURYSM; ARTICLE; BACTERIAL INFECTION; BRAZIL; CHILD; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; FACIAL NERVE PARALYSIS; FEMALE; FEVER; HEPATITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; RECOMMENDED DRUG DOSE; RHEUMATIC DISEASE; RISK FACTOR; SCHOOL CHILD; SENSORY DYSFUNCTION; SINGLE DRUG DOSE; THROMBOCYTOPENIA; THROMBOCYTOSIS; TREATMENT DURATION; TREATMENT RESPONSE; UVEITIS; VACCINATION REACTION; VIRUS INFECTION; DELAYED DIAGNOSIS; HEALTH; HEALTH CARE FACILITY; RETROSPECTIVE STUDY;

BRAZIL; CHILD; CHILD, PRESCHOOL; DELAYED DIAGNOSIS; FEMALE; HEALTH FACILITIES; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; URBAN HEALTH;

EID: 78649529762     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gedalia A. Kawasaki disease: 40 years after the original report: Curr Rheumatol Rep 2007; 9:336-41.
2. Senzaki H. Long-Term Outcome of Kawasaki Disease. Circulation 2008;118: 2763-72.
3. Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan: Pediatrics 2001; 107:e33. http://www.pediatrics.org/cgi/content/full/107/3/e33 [Acesso:15/12/2007].
4. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki Syndrome hospitalizations in the United States in 1997 and 2000. Pediatrics 2003; 112:495-501.
5. Newburger JW, Taubert KA, Shulman ST, Rowley AH, Gewitz MH, Takahashi M et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium. Pediatr Res 2003; 53:153-87.
6. Burns JC, Glodé MP. Kawasaki syndrome. Lancet 2004; 364:533-44.
7. Dominguez SR, Anderson MS, Glodé MP, Robinson CC, Holmes KV. Blinded Case-Control Study of the Relationship between Human Coronavirus NL63 and Kawasaki Syndrome. JID 2006, 94:1697-701.
8. Burns JC, Taubert K, Rowley AH, Newburger JW, Gewitz M, Takahashi M et al. Summary of the 8th International Kawasaki Disease Symposium [Presentation], 2006.
9. Kawasaki T, Kasaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymphnode syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54:271-6.
10. Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T et al. Kawasaki Disease: A Brief History. Pediatrics 2000; 106:e27. http://www.pediatrics.org/cgi/content/full/106/2/e27 [Acesso: 15/12/2007].
11. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y et al. Long-term consequences of Kawasaki disease. A 10 to 21 year follow-up study of 594 patients. Circulation 1996; 94:1379-85.
12. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87:1776-80.
13. Royle J, Burgner D, Curtis N. The Diagnosis and management of Kawasaki disease. J Pediatr 2005; 41:87-93.
14. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991; 119:279-82.
15. American Heart Association Scientific Statement. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease. Circulation 2004; 110:2747-71.
16. Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diagnosis, management, and long-term implications. Cardiol Rev 2007; 15:163-9.
17. Tomikawa SO, Sakamoto RA, Gonçalves AMF, Rodrigues Neto AJ, Sakane PT. A dificuldade diagnóstica na doença de Kawasaki: relato de caso. Pediatria 2003; 25:128-33.
18. Maconochie IK. Kawasaki Disease. Arch dis Child Pract Ed 2004; 89:3-8.
19. Kawasaki T. MCLS - Clinical observation of 50 cases [in Japanese]. Jap J Allerg 1967; 16:178-222.
20. Chang LY, Chang IS, Lu CY, Chiang BL, Lee CY, Chen PJ et al. Epidemiologic features of Kawasaki disease in Taiwan 1996-2002. Pediatrics 2004; 114:678-82.
21. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995; 126:524-9.
22. Meissner HC, Leung DYM. Kawasaki Syndrome: Where are the answers? Pediatrics 2003; 112:672-6.
23. Burns JC, Edmund VC, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatmen in Kawasaki disease. Pediatr Infect Dis J 1998; 17:1144-8.
24. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000; 105:e78. http://www.pediatrics.org/cgi/content/full/105/6/e78 [Acesso: 15/12/2007].
25. Han RK, Sinclair B, Newman A, Silverman ED, Taylor GW, Walsh P et al. Recognition and management of Kawasaki disease. CMAJ 2000; 21:162-6.
26. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65:936-41.